AprilBio Co.,Ltd. (KOSDAQ:397030)

AprilBio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	485,470	363,457	363,525	185,346	-	-
Market Cap Growth	-13.48%	-0.02%	96.13%	-	-	-
Enterprise Value	395,617	291,198	296,211	114,030	-	-
Last Close Price	21550.00	16200.00	16850.00	8775.00	-	-
PE Ratio	21.07	18.17	-	-	-	-
PS Ratio	16.35	13.21	-	926.73	-	-
PB Ratio	5.26	4.00	6.30	2.68	-	-
P/TBV Ratio	5.29	4.02	6.33	2.69	-	-
P/FCF Ratio	21.71	16.89	-	-	-	-
P/OCF Ratio	21.45	16.55	-	-	-	-
EV/Sales Ratio	13.33	10.58	-	570.15	-	-
EV/EBITDA Ratio	19.81	16.57	-	-	-	-
EV/EBIT Ratio	20.52	17.26	-	-	-	-
EV/FCF Ratio	17.69	13.54	-	-	-	-
Debt / Equity Ratio	0.04	0.03	0.10	0.01	0.01	-0.38
Debt / EBITDA Ratio	0.16	0.18	-	-	0.07	-
Debt / FCF Ratio	0.14	0.14	-	-	0.14	-
Asset Turnover	0.33	0.31	-	0.00	0.58	-
Quick Ratio	11.46	11.33	2.95	38.63	14.54	0.86
Current Ratio	11.52	11.39	3.07	38.81	14.68	0.90
Return on Equity (ROE)	30.45%	26.90%	-22.27%	-14.18%	-186.52%	-
Return on Assets (ROA)	13.44%	11.76%	-11.10%	-10.83%	6.88%	-41.42%
Return on Capital (ROIC)	15.25%	13.37%	-12.57%	-11.29%	9.73%	-2566.28%
Return on Capital Employed (ROCE)	20.90%	18.50%	-	-	7.80%	-
Earnings Yield	4.66%	5.50%	-3.89%	-4.83%	-	-
FCF Yield	4.61%	5.92%	-2.91%	-3.67%	-	-
Buyback Yield / Dilution	8.17%	-2.66%	-9.11%	-134.61%	-139.04%	-400.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.